[go: up one dir, main page]

DK608589D0 - CHEMICAL PROCEDURE - Google Patents

CHEMICAL PROCEDURE

Info

Publication number
DK608589D0
DK608589D0 DK608589A DK608589A DK608589D0 DK 608589 D0 DK608589 D0 DK 608589D0 DK 608589 A DK608589 A DK 608589A DK 608589 A DK608589 A DK 608589A DK 608589 D0 DK608589 D0 DK 608589D0
Authority
DK
Denmark
Prior art keywords
chemical procedure
procedure
chemical
Prior art date
Application number
DK608589A
Other languages
Danish (da)
Original Assignee
Holm Arne
Houen Gunnar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holm Arne, Houen Gunnar filed Critical Holm Arne
Priority to DK608589A priority Critical patent/DK608589D0/en
Publication of DK608589D0 publication Critical patent/DK608589D0/en
Priority to PCT/DK1990/000311 priority patent/WO1991008220A1/en
Priority to AU68929/91A priority patent/AU6892991A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
DK608589A 1989-12-01 1989-12-01 CHEMICAL PROCEDURE DK608589D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK608589A DK608589D0 (en) 1989-12-01 1989-12-01 CHEMICAL PROCEDURE
PCT/DK1990/000311 WO1991008220A1 (en) 1989-12-01 1990-11-30 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines
AU68929/91A AU6892991A (en) 1989-12-01 1990-11-30 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK608589A DK608589D0 (en) 1989-12-01 1989-12-01 CHEMICAL PROCEDURE

Publications (1)

Publication Number Publication Date
DK608589D0 true DK608589D0 (en) 1989-12-01

Family

ID=8147293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK608589A DK608589D0 (en) 1989-12-01 1989-12-01 CHEMICAL PROCEDURE

Country Status (3)

Country Link
AU (1) AU6892991A (en)
DK (1) DK608589D0 (en)
WO (1) WO1991008220A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2745351B2 (en) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 Peptide derivatives and their uses
AU665599B2 (en) * 1991-11-08 1996-01-11 Hemosol Inc. Hemoglobins as drug delivery agents
FR2686899B1 (en) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5557033A (en) * 1992-09-22 1996-09-17 Regents Of The University Of Minnesota Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide
US5670347A (en) 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
WO1996000087A2 (en) * 1994-06-24 1996-01-04 Akzo Nobel N.V. Kit for pretargeting and novel pretargeting conjugates
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
DE19636889A1 (en) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastic transferrin and albumin conjugates of cytostatic compounds from the group of the anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and medicaments containing them
CA2301799C (en) * 1997-11-07 2007-08-07 Conjuchem, Inc. Novel conjugates of opioids and endogenous carriers
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
EP1167383B1 (en) * 1997-11-07 2003-03-26 Conjuchem, Inc. Novel conjugates of opioids and endogenous carriers
WO2000069911A1 (en) 1999-05-17 2000-11-23 Conjuchem, Inc. Long lasting insulinotropic peptides
US6706892B1 (en) 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
AU2001274809A1 (en) 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
BR0206919A (en) 2001-02-02 2004-07-06 Conjuchem Inc Long-Term Growth Hormone Release Factor Derivatives
AU2002233089B2 (en) 2001-02-16 2005-12-22 Conjuchem Biotechnologies Inc. Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
EP2990417A1 (en) 2001-12-21 2016-03-02 Human Genome Sciences, Inc. Albumin insulin fusion protein
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2047413C3 (en) * 1970-09-26 1980-05-29 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Process for the production of peptides in a homogeneous phase
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4596674A (en) * 1984-09-11 1986-06-24 Merck & Co., Inc. Immunogenic HAV peptides
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
FR2612519B1 (en) * 1987-03-20 1989-12-15 Rhone Merieux NOVEL PEPTIDE FRACTIONS INDUCING PROTECTIVE ANTIBODIES AGAINST BOVINE LEUKEMIA VIRUS, PROCESS FOR OBTAINING SUCH FRACTIONS, THEIR ENCODING SEQUENCES AND VACCINES MADE FROM SUCH FRACTIONS
DE3806198A1 (en) * 1988-02-04 1989-08-17 Boehringer Mannheim Gmbh IMMUNOGENS AND ITS USE TO OBTAIN ANTIBODIES AGAINST HBA (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) C (DOWN ARROW)

Also Published As

Publication number Publication date
AU6892991A (en) 1991-06-26
WO1991008220A1 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
DK608589D0 (en) CHEMICAL PROCEDURE
FI901319A7 (en) Improved chemical compounds
BR9000014A (en) CLASSIFICAODR
FI900499A7 (en) Chemical method
FI910059A7 (en) Chemical compounds
BR8907374A (en) CHEMICAL COMPOST
BR9001818A (en) ALMOST-OPTICAL GYROTROM
ATA149789A (en) RAILWHEEL
DK164309C (en) MNEMOTECHNICAL AID
DD284561A5 (en) CHIPTRAEGER
DK474289D0 (en) CHEMICAL COMPOUNDS
MX9102047A (en) CHEMICAL PROCEDURE
BR8902705A (en) CARREPIPA
BR6902005U (en) TURN-TRACK
BR8905416A (en) CONTINUATOR
BR8905026A (en) MULTIUTILITARY BABADOURO
BR8904521A (en) ARQUINHO
BR8904228A (en) SKIRT-ABAJUR
BR8904110A (en) SUBSOLATOR
BR8903923A (en) FORM-FACIL
BR8902938A (en) LETRAMATICA
BR8902801A (en) VESETTE
SE8903429D0 (en) OLJELAENSA
BR8901832A (en) RODOMETER
BR8901287A (en) SEED-INTERCALER

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment